Email bulletin archive

Archive

December 2013

• Sofosbuvir and simeprevir approvals
• Price and access to hepatitis C drugs
• AbbVie’s interferon-free combination
• Faldaprevir, new HCV protease inhibitor
• Impact of treatment on subsequent risk of liver-related death
• Other news
• Is your organisation listed in the infohep services database?

November 2013

• News from the Liver Meeting
• How to distinguish between new hepatitis C drugs
• New treatment options for hepatitis C are approaching
• Progress towards interferon-free treatment
• Genotypes 2 and 3
• Liver transplantation
• Screening
• Hepatitis B treatment
• HIV / HCV co-infection
• Justri slides
• Is your organisation listed in the infohep services database?

October 2013

• Diet, nutrition and metabolic disorders
• Screening for hepatitis C
• Hepatitis B transmission
• HIV/hepatitis C co-infection
• New drugs to treat hepatitis C
• Next month: Coverage of the American Liver Meeting
• Selected news and resources from other websites
• Is your organisation listed in the infohep services database?

September 2013

• Testing for hepatitis C
• New drugs: simeprevir and sofosbuvir
• Access to hepatitis C treatment
• Hepatitis B vaccination
• Other news
• Is your organisation listed in the infohep services database?

August 2013

• World Hepatitis Day news
• World Hepatitis Day events
• Access to hepatitis C treatment for people who inject drugs
• Eltrombopag in the European Union
• New drugs for treatment of hepatitis C
• Access to treatment for viral hepatitis
• World Hepatitis Day, 28 July
• Is your organisation listed in the infohep services database?

July 2013

• Drug interactions of telaprevir and boceprevir
• Interferon-free regimens
• Starting treatment
• Future cost of hepatitis C treatment
• The hepatitis C drug development pipeline
• World Hepatitis Day, 28 July
• ELPA on World Hepatitis Day
• Is your organisation listed in the infohep services database?

June 2013

• New treatments for hepatitis C
• HCV treatment after liver transplantation
• European prevalence of viral hepatitis
• HCV treatment as prevention and access to treatment
• News from other sources: selected highlights
• World Hepatitis Alliance plans for World Hepatitis Day
• Is your organisation listed in the infohep services database?

May 2013

• Introducing infohep.org
• Introducing the infohep news bulletin
• The International Liver Congress
• Interferon-free treatment for hepatitis C
• Triple-drug therapies including interferon
• Shorter treatment courses
• Differences between HCV genotypes
• Treatment for hepatitis B
• Compassionate access to HCV drugs
• Global access to HCV drugs
• Infohep.org launches at the International Liver Congress
• Is your organisation listed in the infohep services database?